Longitudinal Improvements in Pediatric Type 1 Diabetes Outcomes: Insights from International Registries

A study, published in The Lancet Diabetes & Endocrinology in November 2024, presents findings from a longitudinal analysis of more than 100,000 children with type 1 diabetes, using data from eight national and one international pediatric diabetes registries. Covering the period from 2013 to 2022, the study focuses on changes in HbA1c levels, treatment regimens, and acute complications, highlighting the positive impact of advancements in diabetes technology.

The study highlights substantial improvements in pediatric diabetes management on an international scale, driven by increased adoption of diabetes technology and stringent HbA1c targets. The Norwegian Childhood Diabetes Registry (NCDR) stands out for its high usage of insulin pumps and CGM, alongside impressive glycemic outcomes and low rates of acute complications. The NCDR has demonstrated significant performance improvements over the study period.

These findings underscore the importance of access to diabetes technology in achieving optimal diabetes care for children. The study advocates for continued advancements and equitable access to diabetes technology to further improve pediatric diabetes outcomes globally.

Oslo Diabetes Research Center congratulates the Norwegian Childhood Diabetes Registry for its outstanding performance and contributions to improving pediatric diabetes care.